The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Airway inflammation in COPD: progress to precision medicine
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity and mortality worldwide, and its prevalence is increasing. Airway inflammation is a consistent feature of COPD and is implicated in the pathogenesis and progression of COPD, but anti-inflammatory therapy is not first-line treatment. The inflammation has many guises and phenotyping this heterogeneity has revealed different patterns. Neutrophil-associated COPD with activation of the inflammasome, T1 and T17 immunity is the most common phenotype with eosinophil-associated T2-mediated immunity in a minority and autoimmunity observed in more severe disease. Biomarkers have enabled targeted anti-inflammatory strategies and revealed that corticosteroids are most effective in those with evidence of eosinophilic inflammation, whereas, in contrast to severe asthma, response to anti-interleukin-5 biologicals in COPD has been disappointing, with smaller benefits for the same intensity of eosinophilic inflammation questioning its role in COPD. Biological therapies beyond T2-mediated inflammation have not demonstrated benefit and in some cases increased risk of infection, suggesting that neutrophilic inflammation and inflammasome activation might be largely driven by bacterial colonisation and dysbiosis. Herein we describe current and future biomarker approaches to assess inflammation in COPD and how this might reveal tractable approaches to precision medicine and unmask important host–environment interactions leading to airway inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824
Papi, A., Brightling, C., Pedersen, S. E., & Reddel, H. K. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33311-1 · Cited by 1,759
Self-citationLung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Lange, P., Celli, B., Agustí, A., Boje Jensen, G., Divo, M., Faner, R., Guerra, S., Marott, J. L., Martinez, F. D., Martinez-Camblor, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411532 · Cited by 1,284
Azithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease
McDonough, J. E., Yuan, R., Suzuki, M., Seyednejad, N., Elliott, W. M., Sanchez, P. G., Wright, A. C., Gefter, W. B., Litzky, L., Coxson, H. O., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106955 · Cited by 1,207
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Self-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
CD8 + T-Lymphocytes in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease
SAETTA, M., Di STEFANO, A., TURATO, G., FACCHINI, F. M., CORBINO, L., MAPP, C. E., MAESTRELLI, P., CIACCIA, A., & FABBRI, L. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9709027 · Cited by 792
Pascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., & Pavord, I. D. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00106-x · Cited by 743
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
Pavord, I. D., Chanez, P., Criner, G. J., Kerstjens, H. A. M., Korn, S., Lugogo, N., Martinot, J.-B., Sagara, H., Albers, F. C., Bradford, E. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708208 · Cited by 625
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D. A., Barer, M. R., Johnston, S. L., Pavord, I. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1553oc · Cited by 612
Self-citationBrightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
Self-citationSeverity of Airflow Limitation Is Associated with Severity of Airway Inflammation in Smokers
DI STEFANO, A., CAPELLI, A., LUSUARDI, M., BALBO, P., VECCHIO, C., MAESTRELLI, P., MAPP, C. E., FABBRI, L. M., DONNER, C. F., & SAETTA, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9802078 · Cited by 572
Ortega, H. G., Yancey, S. W., Mayer, B., Gunsoy, N. B., Keene, O. N., Bleecker, E. R., Brightling, C. E., & Pavord, I. D. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30031-5 · Cited by 559
Self-citationEosinophilic inflammation in COPD: prevalence and clinical characteristics
Singh, D., Kolsum, U., Brightling, C. E., Locantore, N., Agusti, A., & Tal-Singer, R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00162414 · Cited by 497
Self-citationLung microbiome dynamics in COPD exacerbations
Wang, Z., Bafadhel, M., Haldar, K., Spivak, A., Mayhew, D., Miller, B. E., Tal-Singer, R., Johnston, S. L., Ramsheh, M. Y., Barer, M. R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01406-2015 · Cited by 459
Self-citationEosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Siva, R., Green, R. H., Brightling, C. E., Shelley, M., Hargadon, B., McKenna, S., Monteiro, W., Berry, M., Parker, D., Wardlaw, A. J., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00146306 · Cited by 453
Self-citationSilver, J. S., Kearley, J., Copenhaver, A. M., Sanden, C., Mori, M., Yu, L., Pritchard, G. H., Berlin, A. A., Hunter, C. A., Bowler, R., et al. (2016) · Nature Immunology · doi:10.1038/ni.3443 · Cited by 446
Bafadhel, M., Peterson, S., De Blas, M. A., Calverley, P. M., Rennard, S. I., Richter, K., & Fagerås, M. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30006-7 · Cited by 442
The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
Rennard, S. I., Fogarty, C., Kelsen, S., Long, W., Ramsdell, J., Allison, J., Mahler, D., Saadeh, C., Siler, T., Snell, P., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-995oc · Cited by 439
Celli, B. R., Locantore, N., Yates, J., Tal-Singer, R., Miller, B. E., Bakke, P., Calverley, P., Coxson, H., Crim, C., Edwards, L. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201110-1792oc · Cited by 432
Postma, D. S., Brightling, C., Baldi, S., Van den Berge, M., Fabbri, L. M., Gagnatelli, A., Papi, A., Van der Molen, T., Rabe, K. F., Siddiqui, S., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30049-9 · Cited by 397
Self-citationExpression of the T Helper 17-Associated Cytokines IL-17A and IL-17F in Asthma and COPD
Doe, C., Bafadhel, M., Siddiqui, S., Desai, D., Mistry, V., Rugman, P., McCormick, M., Woods, J., May, R., Sleeman, M. A., et al. (2010) · Chest · doi:10.1378/chest.09-3058 · Cited by 394
Self-citationSakornsakolpat, P., Prokopenko, D., Lamontagne, M., Reeve, N. F., Guyatt, A. L., Jackson, V. E., Shrine, N., Qiao, D., Bartz, T. M., Kim, D. K., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0342-2 · Cited by 384
Self-citationBrightling, C. E. (2005) · Thorax · doi:10.1136/thx.2004.032516 · Cited by 369
Self-citationBenralizumab for the Prevention of COPD Exacerbations
Criner, G. J., Celli, B. R., Brightling, C. E., Agusti, A., Papi, A., Singh, D., Sin, D. D., Vogelmeier, C. F., Sciurba, F. C., Bafadhel, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905248 · Cited by 351
Self-citationKearley, J., Silver, J. S., Sanden, C., Liu, Z., Berlin, A. A., White, N., Mori, M., Pham, T.-H., Ward, C. K., Criner, G. J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.011 · Cited by 346
Christenson, S. A., Steiling, K., van den Berge, M., Hijazi, K., Hiemstra, P. S., Postma, D. S., Lenburg, M. E., Spira, A., & Woodruff, P. G. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1458oc · Cited by 329
Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease
George, L., & Brightling, C. E. (2016) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315609251 · Cited by 326
Self-citationBrightling, C. E., Bleecker, E. R., Panettieri, R. A., Bafadhel, M., She, D., Ward, C. K., Xu, X., Birrell, C., & van der Merwe, R. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70187-0 · Cited by 315
Self-citationUnderstanding Society Scientific Group, Wain, L. V., Geisinger-Regeneron DiscovEHR Collaboration, Shrine, N., Artigas, M. S., Erzurumluoglu, A. M., Noyvert, B., Bossini-Castillo, L., Obeidat, M., Henry, A. P., et al. (2017) · Nature Genetics · doi:10.1038/ng.3787 · Cited by 288
Self-citationCXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease
Rennard, S. I., Dale, D. C., Donohue, J. F., Kanniess, F., Magnussen, H., Sutherland, E. R., Watz, H., Lu, S., Stryszak, P., Rosenberg, E., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0992oc · Cited by 261
Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD
Mahler, D. A., Huang, S., Tabrizi, M., & Bell, G. M. (2004) · Chest · doi:10.1378/chest.126.3.926 · Cited by 261
Yun, J. H., Lamb, A., Chase, R., Singh, D., Parker, M. M., Saferali, A., Vestbo, J., Tal-Singer, R., Castaldi, P. J., Silverman, E. K., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.04.010 · Cited by 249
The role of IL-5 in IgA B cell differentiation.
Harriman, G. R., Kunimoto, D. Y., Elliott, J. F., Paetkau, V, & Strober, W. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.3033 · Cited by 240
Small Airway Dimensions in Smokers with Obstruction to Airflow
Bosken, C. H., Wiggs, B. R., Paré, P. D., & Hogg, J. C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.563 · Cited by 235
Caramori, G., Casolari, P., Barczyk, A., Durham, A. L., Di Stefano, A., & Adcock, I. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0561-5 · Cited by 220
Precision medicine in airway diseases: moving to clinical practice
Agustí, A., Bafadhel, M., Beasley, R., Bel, E. H., Faner, R., Gibson, P. G., Louis, R., McDonald, V. M., Sterk, P. J., Thomas, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01655-2017 · Cited by 215
Han, M. K., Tayob, N., Murray, S., Dransfield, M. T., Washko, G., Scanlon, P. D., Criner, G. J., Casaburi, R., Connett, J., Lazarus, S. C., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0207oc · Cited by 193
What is early COPD and why is it important?
Soriano, J. B., Polverino, F., & Cosío, B. G. (2018) · European Respiratory Journal · doi:10.1183/13993003.01448-2018 · Cited by 180
Kim, V., & Aaron, S. D. (2018) · European Respiratory Journal · doi:10.1183/13993003.01261-2018 · Cited by 179
Lehman, S. M., Mearns, G., Rankin, D., Cole, R. L., Smrekar, F., Branston, S. D., & Morales, S. (2019) · Viruses · doi:10.3390/v11010088 · Cited by 179
Min, X., Yu, B., & Wang, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-39071-y · Cited by 170
Small Airway Obstruction in COPD
Hogg, J. C., McDonough, J. E., & Suzuki, M. (2013) · Chest · doi:10.1378/chest.12-1766 · Cited by 169
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
Bafadhel, M., Davies, L., Calverley, P. M. A., Aaron, S. D., Brightling, C. E., & Pavord, I. D. (2014) · European Respiratory Journal · doi:10.1183/09031936.00062614 · Cited by 167
Self-citationVasilescu, D. M., Martinez, F. J., Marchetti, N., Galbán, C. J., Hatt, C., Meldrum, C. A., Dass, C., Tanabe, N., Reddy, R. M., Lagstein, A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201811-2083oc · Cited by 162
Ghebre, M. A., Pang, P. H., Diver, S., Desai, D., Bafadhel, M., Haldar, K., Kebadze, T., Cohen, S., Newbold, P., Rapley, L., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.04.013 · Cited by 161
Self-citationWang, Z., Singh, R., Miller, B. E., Tal‐Singer, R., Horn, S. V., Tomsho, L., Mackay, A. J., Allinson, J. P., Webb, A. J., Brookes, A. J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210741 · Cited by 158
Self-citationde Vries, R., Dagelet, Y. W. F., Spoor, P., Snoey, E., Jak, P. M. C., Brinkman, P., Dijkers, E., Bootsma, S., Elskamp, F., de Jongh, F. H., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.01817-2017 · Cited by 147
Blood and sputum eosinophils in COPD; relationship with bacterial load
Kolsum, U., Donaldson, G. C., Singh, R., Barker, B. L., Gupta, V., George, L., Webb, A. J., Thurston, S., Brookes, A. J., McHugh, T. D., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0570-5 · Cited by 144
Self-citationGhebre, M. A., Bafadhel, M., Desai, D., Cohen, E. S., Newbold, P., Rapley, L., Woods, J., Rugman, P., Pavord, I. D., Newby, C., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.035 · Cited by 140
Self-citationFirst Study of Infliximab Treatment in Patients with Chronic Obstructive Pulmonary Disease
van der Vaart, H., Koëter, G. H., Postma, D. S., Kauffman, H. F., & ten Hacken, N. H. T. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-147oc · Cited by 140
Hartley, R. A., Barker, B. L., Newby, C., Pakkal, M., Baldi, S., Kajekar, R., Kay, R. A., Laurencin, M., Marshall, R. P., Sousa, A. R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.02.001 · Cited by 124
Self-citationInnate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Stefano, A. D., Caramori, G., Barczyk, A., Vicari, C., Brun, P., Zanini, A., Cappello, F., Garofano, E., Padovani, A., Contoli, M., et al. (2013) · European Respiratory Journal · doi:10.1136/thoraxjnl-2012-203062 · Cited by 123
Woodruff, P. G., van den Berge, M., Boucher, R. C., Brightling, C. E., Burchard, E. G., Christenson, S. A., Han, M. K., Holtzman, M. J., Kraft, M., Lynch, D. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0973ws · Cited by 123
Self-citationChristenson, S. A., van den Berge, M., Faiz, A., Inkamp, K., Bhakta, N. R., Bonser, L. R., Zlock, L. T., Barjaktarević, I., Barr, R. G., Bleecker, E. R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121087 · Cited by 117
Anti-Tissue Antibodies Are Related to Lung Function in Chronic Obstructive Pulmonary Disease
Núñez, B., Sauleda, J., Antó, J. M., Juliá, M. R., Orozco‐Levi, M., Monsó, E., Noguera, A., Gómez, F. P., García‐Aymerich, J., & Agustí, A. G. N. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0029oc · Cited by 110
Brightling, C. E., Monterio, W., GREEN, R. H., Parker, D., Morgan, M. D. L., Wardlaw, A. J., & Pavord, I. D. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1195 · Cited by 109
Self-citationBarker, B. L., Haldar, K., Patel, H., Pavord, I. D., Barer, M. R., Brightling, C. E., & Bafadhel, M. (2014) · CHEST Journal · doi:10.1378/chest.14-0764 · Cited by 104
Self-citationTNFα Antagonists for Acute Exacerbations of COPD: A Randomised Double-Blind Controlled Trial
Aaron, S. D., Vandemheen, K. L., Maltais, F., Field, S. K., Sin, D. D., Bourbeau, J., Marciniuk, D. D., FitzGerald, J. M., Nair, P., & Mallick, R. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202432 · Cited by 103
Turino, G. M., Senior, R. M., Garg, B. D., Keller, S. E., Levi, M., & Mandl, I. (1969) · Science · doi:10.1126/science.165.3894.709 · Cited by 100
Calverley, P. M. A., Sethi, S., Dawson, M., Ward, C. K., Finch, D. K., Penney, M., Newbold, P., & van der Merwe, R. (2017) · Respiratory Research · doi:10.1186/s12931-017-0633-7 · Cited by 100
Kirsten, A., Förster, K., Radeczky, E., Linnhoff, A., Bálint, B., Watz, H., Wray, H., Salkeld, L., Cullberg, M., & Larsson, B. S. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.02.001 · Cited by 92
A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease
Eich, A., Urbán, V. S., Jutel, M., Vlček, J., Shim, J. J., Трофимов, В. И., Liam, C. K., Kuo, P., Hou, Y., Xiao, J., et al. (2017) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2017.1335697 · Cited by 86
The cellular and molecular determinants of emphysematous destruction in COPD
Suzuki, M., Sze, M. A., Campbell, J. D., Brothers, J. F., Lenburg, M. E., McDonough, J. E., Elliott, W. M., Cooper, J. D., Spira, A. E., & Hogg, J. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-10126-2 · Cited by 65
Increased IgA Expression in Lung Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease
Ladjemi, M. Z., Martin, C., Lecocq, M., Detry, B. R., Nana, F. A., Moulin, C., Weynand, B., Fregimilicka, C., Bouzin, C., Thurion, P., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201802-0352oc · Cited by 62
Rabe, K. F., Watz, H., Baraldo, S., Pedersen, F., Biondini, D., Bagul, N. B., Hanauer, G., Göhring, U., Purkayastha, D., Román, J., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30331-x · Cited by 60
Introduction to precision medicine in COPD
Leung, J. M., Obeidat, M., Sadatsafavi, M., & Sin, D. D. (2019) · European Respiratory Journal · doi:10.1183/13993003.02460-2018 · Cited by 60
Why we need a vaccine for non-typeable Haemophilus influenzae
Cerquetti, M., & Giufrè, M. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1174354 · Cited by 51
New and emerging drug treatments for severe asthma
Diver, S. E., RUSSELL, R. J., & Brightling, C. E. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13086 · Cited by 45
Self-citationCOPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging
Washko, G. R., & Párraga, G. (2018) · European Respiratory Journal · doi:10.1183/13993003.01570-2018 · Cited by 43
Greulich, T., Hohlfeld, J. M., Neuser, P., Lueer, K., Klemmer, A., Schade‐Brittinger, C., Harnisch, S., Garn, H., Renz, H., Homburg, U., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0751-x · Cited by 40
Biologic Drugs: A New Target Therapy in COPD?
Yousuf, A., & Brightling, C. E. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1437897 · Cited by 40
Self-citationAutoinflammatory disease in the lung
Scambler, T., Holbrook, J. A., Savic, S., McDermott, M., & Peckham, D. G. (2018) · Immunology · doi:10.1111/imm.12937 · Cited by 40
Cited by
Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke
Hikichi, M., Mizumura, K., Maruoka, S., & Gon, Y. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.43 · Cited by 283
Metadata
- Authors
- Brightling, C., & Greening, N.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-05-09
- Volume
- 54
- Issue
- 2
- Pages
- 1900651
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2944047291
- Cited by
- 419
- References
- 75
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.